000
| 01041nam 2200229za 4500 |
---|
001 | 9.699195 |
---|
003 | CaOODSP |
---|
005 | 20210625000254 |
---|
007 | cr ||||||||||| |
---|
008 | 150407s2014||||xxc|||||o f|0| 0 eng d |
---|
020 | |a978-1-100-23516-5 |
---|
040 | |aCaOODSP|beng |
---|
043 | |an-cn--- |
---|
086 | 1 |aHP40-104/2014E-PDF |
---|
110 | 2 |aPublic Health Agency of Canada. |
---|
245 | 10|aAdvice for the use of the multicomponent meningococcal serogroup B (4CMenB) vaccine : |h[electronic resource] |
---|
246 | 1 |iAt head of title: |aAdvisory Committee Statement (ACS), National Advisory Committee on Immunization |
---|
260 | |aOttawa - Ontario : |bPublic Health Agency of Canada |cApril 2014. |
---|
300 | |a43p.|bgraphs, references, tables |
---|
590 | |a14-16|b2014-04-17 |
---|
775 | 08|tConseils relatifs à l'utilisation du vaccin multicomposant contre le méningocoque du sérogroupe B (4CMenB) |w(CaOODSP)9.643156 |
---|
856 | 40|ahttp://publications.gc.ca|qPDF|s664 KB|uhttps://publications.gc.ca/collections/collection_2014/aspc-phac/HP40-104-2014-eng.pdf |
---|